fipamezole: Clinical Trials

2 trials of fipamezole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow fipamezole: new trials by email Literature Review of fipamezole trials Research Report on fipamezole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fipamezole in Neurogenic Orthostatic Hypotension
Placebo, Fipamezole - Symptomatic Neurogenic Orthostatic Hypotension (NOH), Parkinson's Disease
Phase 2UnknownJuvantia Pharma Ltd242008-09-012008-10-01
Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
fipamezole - Parkinson's Disease
Phase 2CompletedJuvantia Pharma Ltd1802007-10-012009-06-03

Conditions studied

Parkinson Disease (2)  ·  Basal Ganglia Diseases (1)  ·  Dyskinesias (1)  ·  Hypotension, Orthostatic (1)  ·  Movement Disorders (1)  ·  Multiple System Atrophy (1)  ·  Olivopontocerebellar Atrophies (1)  ·  Pure Autonomic Failure (1)  ·  Shy-Drager Syndrome (1)  ·  Striatonigral Degeneration (1)

Sponsors

Juvantia Pharma Ltd (2)

Countries

France (1)  ·  India (1)  ·  Portugal (1)  ·  United States (1)

Top investigators

Olivier Rascol, MD (1)  ·  Peter A. LeWitt, M.D. (1)